Association between hepatitis B virus core promoter rearrangements and hepatocellular carcinoma

Tomasz Laskus, Marek Radkowski, Marek Nowicki, Lian Fu Wang, Hugo E Vargas, Jorge Rakela

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Hepatitis B virus (HBV) is the major etiological agent of hepatocellular carcinoma (HCC). Whether any particular viral variants are associated with HCC is unknown. We studied 53 Gambian patients with HCC and 33 HBsAg positive controls. A functional part of HBV core promoter and whole precore region were sequenced directly and/or after cloning. HBV DNA was amplified from sera from 27 HCC patients and in all controls. Fourteen (52%) patients and 12 (36%) controls (NS) were found to harbor an HBV strain with G to A transition mutation at position 1896 leading to HBeAg negative phenotype. Nine (33%) HCC patients and 2 (6%) controls (p < 0.01) harbored a mixture of wild type and HBV strains with deletions/insertions; strong consensus sequences for topoisomerase I breakage were located in the vicinity of these changes. In Africa, HCC is associated with HBV strains that have deletions/insertions in the HBV core promoter region.

Original languageEnglish (US)
Pages (from-to)812-814
Number of pages3
JournalBiochemical and Biophysical Research Communications
Volume244
Issue number3
DOIs
StatePublished - Mar 27 1998
Externally publishedYes

Fingerprint

Viruses
Hepatitis B virus
Hepatocellular Carcinoma
Type I DNA Topoisomerase
Hepatitis B e Antigens
Cloning
Consensus Sequence
Hepatitis B Surface Antigens
Ports and harbors
Genetic Promoter Regions
Organism Cloning
Phenotype
Mutation
DNA
Serum

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Association between hepatitis B virus core promoter rearrangements and hepatocellular carcinoma. / Laskus, Tomasz; Radkowski, Marek; Nowicki, Marek; Wang, Lian Fu; Vargas, Hugo E; Rakela, Jorge.

In: Biochemical and Biophysical Research Communications, Vol. 244, No. 3, 27.03.1998, p. 812-814.

Research output: Contribution to journalArticle

@article{7b0d20f843a94a6e8bbd48e6170262f6,
title = "Association between hepatitis B virus core promoter rearrangements and hepatocellular carcinoma",
abstract = "Hepatitis B virus (HBV) is the major etiological agent of hepatocellular carcinoma (HCC). Whether any particular viral variants are associated with HCC is unknown. We studied 53 Gambian patients with HCC and 33 HBsAg positive controls. A functional part of HBV core promoter and whole precore region were sequenced directly and/or after cloning. HBV DNA was amplified from sera from 27 HCC patients and in all controls. Fourteen (52{\%}) patients and 12 (36{\%}) controls (NS) were found to harbor an HBV strain with G to A transition mutation at position 1896 leading to HBeAg negative phenotype. Nine (33{\%}) HCC patients and 2 (6{\%}) controls (p < 0.01) harbored a mixture of wild type and HBV strains with deletions/insertions; strong consensus sequences for topoisomerase I breakage were located in the vicinity of these changes. In Africa, HCC is associated with HBV strains that have deletions/insertions in the HBV core promoter region.",
author = "Tomasz Laskus and Marek Radkowski and Marek Nowicki and Wang, {Lian Fu} and Vargas, {Hugo E} and Jorge Rakela",
year = "1998",
month = "3",
day = "27",
doi = "10.1006/bbrc.1998.8249",
language = "English (US)",
volume = "244",
pages = "812--814",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Association between hepatitis B virus core promoter rearrangements and hepatocellular carcinoma

AU - Laskus, Tomasz

AU - Radkowski, Marek

AU - Nowicki, Marek

AU - Wang, Lian Fu

AU - Vargas, Hugo E

AU - Rakela, Jorge

PY - 1998/3/27

Y1 - 1998/3/27

N2 - Hepatitis B virus (HBV) is the major etiological agent of hepatocellular carcinoma (HCC). Whether any particular viral variants are associated with HCC is unknown. We studied 53 Gambian patients with HCC and 33 HBsAg positive controls. A functional part of HBV core promoter and whole precore region were sequenced directly and/or after cloning. HBV DNA was amplified from sera from 27 HCC patients and in all controls. Fourteen (52%) patients and 12 (36%) controls (NS) were found to harbor an HBV strain with G to A transition mutation at position 1896 leading to HBeAg negative phenotype. Nine (33%) HCC patients and 2 (6%) controls (p < 0.01) harbored a mixture of wild type and HBV strains with deletions/insertions; strong consensus sequences for topoisomerase I breakage were located in the vicinity of these changes. In Africa, HCC is associated with HBV strains that have deletions/insertions in the HBV core promoter region.

AB - Hepatitis B virus (HBV) is the major etiological agent of hepatocellular carcinoma (HCC). Whether any particular viral variants are associated with HCC is unknown. We studied 53 Gambian patients with HCC and 33 HBsAg positive controls. A functional part of HBV core promoter and whole precore region were sequenced directly and/or after cloning. HBV DNA was amplified from sera from 27 HCC patients and in all controls. Fourteen (52%) patients and 12 (36%) controls (NS) were found to harbor an HBV strain with G to A transition mutation at position 1896 leading to HBeAg negative phenotype. Nine (33%) HCC patients and 2 (6%) controls (p < 0.01) harbored a mixture of wild type and HBV strains with deletions/insertions; strong consensus sequences for topoisomerase I breakage were located in the vicinity of these changes. In Africa, HCC is associated with HBV strains that have deletions/insertions in the HBV core promoter region.

UR - http://www.scopus.com/inward/record.url?scp=0032571140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032571140&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1998.8249

DO - 10.1006/bbrc.1998.8249

M3 - Article

C2 - 9535748

AN - SCOPUS:0032571140

VL - 244

SP - 812

EP - 814

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -